Drug Insight: bleeding after percutaneous coronary intervention-risks, measures and impact of anticoagulant treatment options
Nature Clinical Practice Cardiovascular Medicine · 2005-09 · 2 (9) · 465-474
DOI: 10.1038/ncpcardio0311 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Nature Clinical Practice Cardiovascular Medicine, 2005-09. Verfasst von Martin T Rothman. Beteiligte Einrichtung: London Chest Hospital, Barts, UK. martin.rothman@bartsandthelondon.nhs.uk. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 61 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- London Chest Hospital, Barts, UK. martin.rothman@bartsandthelondon.nhs.uk
Zitieren
APA
Rothman, M. T. (2005). Drug Insight: bleeding after percutaneous coronary intervention-risks, measures and impact of anticoagulant treatment options. Nature Clinical Practice Cardiovascular Medicine, 2(9), 465-474. https://doi.org/10.1038/ncpcardio0311
Vancouver
Rothman MT. Drug Insight: bleeding after percutaneous coronary intervention-risks, measures and impact of anticoagulant treatment options. Nature Clinical Practice Cardiovascular Medicine. 2005;2(9):465-474. doi:10.1038/ncpcardio0311
BibTeX
@article{Rothman2005,
author = {Rothman, Martin T},
title = {Drug Insight: bleeding after percutaneous coronary intervention-risks, measures and impact of anticoagulant treatment options},
journal = {Nature Clinical Practice Cardiovascular Medicine},
year = {2005},
volume = {2},
number = {9},
pages = {465--474},
doi = {10.1038/ncpcardio0311}
}
EUVIMED